Antibiotic resistance and bacterial infections are a large threat to modern healthcare. The Norwegian company SoftOx Solutions has developed a patented technology with the potential of becoming a game changer in fighting infections. To achieve this SoftOx has a highly competent organization and established a long-term relationship with leading scientists from the University of Copenhagen and Excite International, Canada. SoftOx wound cleansing solution shall become the first antiseptic with solid clinical evidence of infection removal in chronic wounds, giving us a unique market position in a 90 billion NOK wound care market.